pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›GABAPENTIN
drug
save

GABAPENTIN

Marketedupdated 3mo ago
by ACI Healthcare USA Inc
Approved
community read0 votes

🐶 often sniffed alongside

top 8
  • tagApproval240 co-mentions · 120 sources
  • drugGralise127 co-mentions · 127 sources
  • drugNeurontin127 co-mentions · 127 sources
  • tagSmall Molecule120 co-mentions · 120 sources
  • companyActavis Elizabeth LLC18 co-mentions · 18 sources
  • companyStrides Pharma Inc13 co-mentions · 13 sources
  • tagRecall7 co-mentions · 7 sources
  • companySun Pharmaceutical Industries Ltd6 co-mentions · 2 sources

indications

investigational
Epilepsy

all catalysts(59)

approval · 59
Sep 12, 2003
approval
23y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Apr 6, 2005
approval
21y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Apr 8, 2005
approval
21y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 23, 2005
approval
21y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 5, 2006
approval
20y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
May 13, 2010
approval
16y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Feb 11, 2011
approval
16y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jun 24, 2011
approval
15y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jun 24, 2011
approval
15y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Aug 30, 2011
approval
15y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Apr 11, 2012
approval
14y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Apr 11, 2012
approval
14y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Aug 28, 2012
approval
14y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Nov 8, 2014
approval
12y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Nov 8, 2014
approval
12y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Mar 16, 2015
approval
11y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jan 13, 2016
approval
11y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jan 13, 2016
approval
11y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Mar 24, 2017
approval
9y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
May 14, 2018
approval
8y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 16, 2018
approval
8y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 21, 2020
approval
6y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 21, 2020
approval
6y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Sep 16, 2020
approval
6y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Sep 16, 2020
approval
6y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 2, 2020
approval
6y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 2, 2020
approval
6y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 28, 2020
approval
6y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 28, 2020
approval
6y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 28, 2020
approval
6y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 28, 2020
approval
6y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 28, 2020
approval
6y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Apr 26, 2021
approval
5y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Sep 9, 2021
approval
5y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Feb 20, 2024
approval
2y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 16, 2024
approval
2y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 16, 2024
approval
2y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 16, 2024
approval
2y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 16, 2024
approval
2y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 16, 2024
approval
2y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Sep 9, 2024
approval
2y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 3, 2024
approval
2y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 19, 2024
approval
2y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 19, 2024
approval
2y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 19, 2024
approval
2y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 19, 2024
approval
2y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jan 7, 2025
approval
2y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jan 7, 2025
approval
2y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Feb 4, 2025
approval
2y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Feb 4, 2025
approval
2y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 21, 2025
approval
1y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 21, 2025
approval
1y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Sep 19, 2025
approval
11mo ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Nov 24, 2025
approval
9mo ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 17, 2025
approval
8mo ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jan 29, 2026
approval
7mo ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jan 29, 2026
approval
7mo ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Mar 6, 2026
approval
6mo ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Apr 2, 2026
approval
5mo ago
GABAPENTIN — FDA approval
GABAPENTIN
→
view all 59 catalysts →

Trials studying GABAPENTIN

  • —Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infantsrecruitingn=1,600
  • —A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweatsactive not recruitingn=999
  • phase1A Study on Ketoprofen Lysine Salt (KLS) + Gabapentin (GABA) vs KLS to Investigate Their Pharmacodynamic in Healthy Malescompletedn=141
  • phase4A Study of Oral Dosing of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patientscompletedn=375
  • phase4Post-marketing Study of Gabapentin Enacarbil to Evaluate the Effect in Restless Leg Syndrome (RLS) Patients With Moderate Renal Impairmentcompletedn=19
  • phase2Effect of PP-01 on Cannabis Withdrawal Syndromecompletedn=234
  • phase4An Abuse Potential Study of Orally Administered HORIZANT in Healthy, Non-dependent, Recreational Drug Userscompletedn=86
  • phase4Gabapentin in Phantom and Stump Paincompleted
more trials →

News(0)

no news has mentioned this drug yet

brand
GABAPENTIN
generic
GABAPENTIN
indication
Partial Seizure
phase
marketed
Data sources
openFDA · ClinicalTrials.gov
last refreshed 3m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?